Carregant...

PS2-35: Variation in Capture of Chemotherapy Data: Preliminary Findings From the CRN Economic Rx Burden Pilot Study

Background: A number of high-cost chemotherapy agents, including targeted biologic and genetic therapies, have been introduced to the U.S. in recent years. Much of the literature on use and costs of these new agents has been derived from clinical trials and Medicare/SEER-based studies. To date, few...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ritzwoller, Debra P., Delate, Tom, Freml, Jared, Clarke, Addie, O’Keeffe-Rosetti, Maureen, Fishman, Paul, Bachman, Donald J., Lafata, Jennifer Elston, Hornbrook, Mark C.
Format: Artigo
Idioma:Inglês
Publicat: Marshfield Clinic 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2842390/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.8.1.35
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!